19 completed, 5 unknown, 3 terminated, 2 withdrawn. 30 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 30 | Completed 19, Unknown 5, Terminated 3, Withdrawn 2, Active not recruiting 1 |
Follow Omacor: new trials by email Literature Review of Omacor trials Research Report on Omacor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood TAK-085, Not treated with omega-3-acid ethyl esters - Hyperlipidemia | Phase 4 | Completed | Takeda | 53 | 2016-12-27 | 2019-02-11 |
| Fish Oils and Adipose Inflammation Reduction Lovaza, Placebo - Obesity | Phase 4 | Completed | University of Pennsylvania | 29 | 2014-06-01 | 2019-02-12 |
| The Effects of Omega-3 Fatty Acids in Renal Transplantation Omega-3 fatty acids, Placebo - Disorder Related to Renal Transplantation | Phase 4 | Completed | Oslo University Hospital | 132 | 2013-11-01 | 2015-12-08 |
| Lovaza Mechanisms of Action Omega 3 fatty acid (Lovaza) - Moderate Hypertriglyceridemia. | Phase 4 | Unknown | Brigham and Women's Hospital | 40 | 2012-08-01 | 2013-02-25 |
| Effect of Omega-3 Fatty Acid on Vitamin D Activation Omega-3 fatty acid ethylester 90, Olive oil, cholecalciferol - Hemodialysis Patients, Vitamin D Insufficiency | Phase 4 | Completed | Dong-A University | 17 | 2012-05-01 | 2015-03-10 |
| Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia Lovaza (Omega-3 acid ethyl esters), Placebo - Hypertriglyceridemia | Phase 4 | Withdrawn | University of Utah | 2010-08-01 | 2016-02-08 | |
| The Impact of Omega Three Fatty Acids on Vascular Function in HIV Lovaza - High Triglyceride Level, HIV Infection | Phase 4 | Completed | Tufts University | 129 | 2010-01-01 | 2020-02-11 |
| Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia P-OM3, Placebo - Primary Hypercholesterolemia | Phase 4 | Completed | Provident Clinical Research | 32 | 2010-01-01 | 2024-05-31 |
| Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD Stimulants plus Lovaza, Stimulants plus placebo - Attention Deficit Hyperactivity Disorder | Phase 4 | Terminated | Antonios Likourezos | 15 | 2009-12-01 | 2023-12-14 |
| Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids OMACOR, Placebo oral capsule - Non-Alcoholic Fatty Liver Disease | Phase 4 | Completed | University Hospital Southampton NHS Foundation Trust | 103 | 2009-11-01 | 2019-10-25 |
| Lovaza® and Microvascular Function in Type 2 Diabetes omega-3-ethyl esters, Placebo - Hypertriglyceridemia, Diabetic Neuropathy | Phase 4 | Completed | Eastern Virginia Medical School | 44 | 2009-10-01 | 2017-05-09 |
| Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects Lovaza, fosamprenavir/ritonavir - Hypertriglyceridemia, HIV Infection | Phase 4 | Completed | Felizarta, Franco, M.D. | 36 | 2009-09-01 | 2012-04-18 |
| Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease Lovaza, placebo control - Non-Alcoholic Fatty Liver Disease | Phase 4 | Unknown | Huntington Medical Research Institutes | 40 | 2009-09-01 | 2010-06-10 |
| Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia Lovaza - High Triglycerides, Hypercholesterolemia | Phase 4 | Completed | Massachusetts General Hospital | 65 | 2009-07-01 | 2017-07-02 |
| The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients Omega-3 acid 4 grams per day, Placebo control - Diabetes Mellitus, Type 2, Hypercholesterolemia | Phase 4 | Unknown | Inje University | 70 | 2009-07-01 | 2009-08-06 |
| Triglyceride Lowering Study Omega-3-Acid Ethyl Esters - Hypertriglyceridemia | Phase 4 | Unknown | Jewish Hospital, Cincinnati, Ohio | 25 | 2009-07-01 | 2009-07-08 |
| Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder Omacor®, Placebo - Borderline Personality Disorder. | Phase 4 | Unknown | Hospital Universitari Vall d'Hebron Research Institute | 102 | 2009-02-01 | 2010-05-27 |
| Efficacy of Fish Oil in Lupus Patients Omega-3, flow-mediated dilation of the brachial artery, corn starch - Systemic Lupus Erythematosus | Phase 4 | Completed | Michelle Petri M.D.,MPH | 106 | 2009-02-01 | 2016-11-18 |
| Effects of Fish Oil on Post Ablation Arrhythmias LOVAZA Omega 3-acid ethyl esters, LOVAZA, placebo - Atrial Fibrillation | Phase 4 | Terminated | University of Michigan | 12 | 2008-11-01 | 2017-09-12 |
| Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial Lovaza, Placebo - Cardiovascular Disease, HIV Infection | Phase 4 | Completed | Tufts University | 41 | 2008-07-01 | 2019-09-11 |
Showing 20 of 30. Sign in to see all of them.
Hypertriglyceridemia (10) · HIV Infections (4) · Atrial Fibrillation (3) · Diabetes Mellitus, Type 2 (3) · Hypercholesterolemia (3) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Diabetes Mellitus (2) · Dyslipidemias (2) · Non-alcoholic Fatty Liver Disease (2) · Arrhythmias, Cardiac (1) · Attention Deficit Disorder with Hyperactivity (1) · Bipolar Disorder (1) · Borderline Personality Disorder (1) · Diabetes Mellitus, Type 1 (1)
GlaxoSmithKline (2) · Provident Clinical Research (2) · Tufts University (2) · Antonios Likourezos (1) · Brigham and Women's Hospital (1) · Chirag Sandesara (1) · Dong-A University (1) · Eastern Virginia Medical School (1) · Felizarta, Franco, M.D. (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Huntington Medical Research Institutes (1) · Inje University (1) · Jewish Hospital, Cincinnati, Ohio (1) · Massachusetts General Hospital (1) · Michelle Petri M.D.,MPH (1)
United States (18) · United Kingdom (4) · Germany (2) · South Korea (2) · Japan (1) · Norway (1) · Spain (1)
Christine A Wanke, MD (2) · Kevin C. Maki, PhD (2) · Aaron I Vinik, MD, PhD (1) · Alin Stirban, MD (1) · Allan Struthers, MD (1) · Charles Glueck, MD (1) · Charles M. Stein (1) · Chirag M Sandesara, MD (1) · Christopher D Byrne, MBBCh PhD (1) · Diethelm Tschoepe, MD, Prof. (1) · Edward A Mena, MD (1) · Eliot A Brinton, MD (1) · Franco Felizarta, MD (1)
PMID 21297494, PMID 15290734, PMID 19597368, PMID 19820283, PMID 20888102, PMID 22212377, PMID 22892157, PMID 23130134, PMID 23293330, PMID 24356795, PMID 24743428, PMID 24988179, PMID 25043514, PMID 25465932, PMID 25636157, PMID 25932792, PMID 26021488, PMID 26272871, PMID 26602219, PMID 26748347, PMID 27106721, PMID 28294174, PMID 29653635, PMID 30125457, PMID 30146931, PMID 30146932, PMID 31986094, PMID 32620337, PMID 34939013, PMID 35393614, PMID 36375174, PMID 36871000, PMID 37058600, PMID 38052385, PMID 38237868, PMID 38385506, PMID 39501183, PMID 40010818, PMID 9048514
K23DK095913 (1), R01DK061486 (1), R01HL087254 (1), R01HL096585 (1)